Back to results
US 8,026,234 B2Granted
Polo-like kinase inhibitors
AssigneeTakeda Pharmaceutical Company Limited
InventorsTakashi Ichikawa, Stephen W. Kaldor
Life of this patent
Estimating the term…
Abstract
Compounds of the following formula are provided for use with kinases: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Claims2
The compound 4-(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.